People · Operator
Named in public records as an officer, director or promoter · active 2008–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Palmaz Scientific Inc | — | Other Health Care | Series B | $75.0M | $29.1M | 2008 |
| Bi02 Medical, Inc. | — | Biotechnology | Series A | $35.6M | $54.2M | 2009 |
Christopher Banas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Banas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Castella | 1 | 6 |
| John Creecy | 1 | 5 |
| Alan Dean | 1 | 2 |
| Steven Bailey | 1 | 2 |
| John Elwood | 1 | 2 |
| Luis Angel | 1 | 1 |
| Steven B Solomon | 1 | 1 |
| Eugene A Sprague | 1 | 1 |
| Julio C Palmaz | 1 | 1 |
| Christopher C Banas | 1 | 1 |
| Philip C Romano | 1 | 1 |
| Philip Romano | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.